Literature DB >> 6340708

Captopril in pulmonary hypertension.

N Kastanos, R Estopa Miró, A Agustí-Vidal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6340708      PMCID： PMC481341          DOI： 10.1136/hrt.49.5.513

Source DB:  PubMed          Journal:  Br Heart J        ISSN： 0007-0769


× No keyword cloud information.
  3 in total

1.  Captopril as treatment for patients with pulmonary hypertension. Problem of variability in assessing chronic drug treatment.

Authors:  S Rich; J Martinez; W Lam; K M Rosen
Journal:  Br Heart J       Date:  1982-09

2.  The role of hydralazine therapy for pulmonary arterial hypertension of unknown cause.

Authors:  E Lupi-Herrera; J Sandoval; M Seoane; D Bialostozky
Journal:  Circulation       Date:  1982-04       Impact factor: 29.690

3.  Deleterious effects of hydralazine in patients with pulmonary hypertension.

Authors:  M Packer; B Greenberg; B Massie; H Dash
Journal:  N Engl J Med       Date:  1982-06-03       Impact factor: 91.245
  3 in total
  1 in total

Review 1.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.